药物对比
Alogliptin vs Repaglinide
Alogliptin vs Repaglinide治疗2型糖尿病的比较：DPP-4抑制剂vs格列奈类。针对2型糖尿病患者的疗效、安全性、副作用及适用性。
此页面暂无可用的对比维度。
临床背景
Triggered when choosing an oral add-on after metformin for type 2 diabetes, comparing DPP-4 inhibitors to meglitinides for postprandial control.
结论
Alogliptin generally offers a safer hypoglycemia profile than Repaglinide, but neither is superior for all patients.
全部药物对比